Copertina

Hybrid closed‐loop therapy significantly improved maternal glucose control during pregnancy complicated by type 1 diabetes

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autore principale:	Iskandar Idris
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Diabetes, Obesity and Metabolism Now
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease
di: Iskandar Idris
Pubblicazione: (2024)

Epigenetic changes shown to cause type 2 diabetes
di: Iskandar Idris
Pubblicazione: (2024)

Appropriate timing of exercise for adults with obesity including those with type 2 diabetes
di: Iskandar Idris
Pubblicazione: (2024)

Can diet and exercise intervention prevent type 2 diabetes in individuals with a high genetic risk?
di: Iskandar Idris
Pubblicazione: (2024)

Extension study from DIRECT showed ongoing remission rate from type 2 diabetes in some patient following very low calorie diet at 5 years
di: Iskandar Idris
Pubblicazione: (2024)

Real world study provided reassurance of the safety of GLP‐1 therapy on mental health and suicide risk
di: Iskandar Idris
Pubblicazione: (2024)

Fenofibrate shown to reduce progression of diabetic retinopathy
di: Iskandar Idris
Pubblicazione: (2024)

Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied
di: Iskandar Idris
Pubblicazione: (2024)

Precision medicine approach to detect obese people who are at high risk of developing diabetes
di: Iskandar Idris
Pubblicazione: (2024)

Tirzepatide shown to improve clinical outcomes for patients with heart failure with preserved ejection fraction (HFpEF) and obesity
di: Iskandar Idris
Pubblicazione: (2024)

The glucagon like peptide‐1 linked to nonarteritic anterior ischemic optic neuropathy
di: Iskandar Idris
Pubblicazione: (2024)

Potential role of glucagon like peptide (GLP)‐1 receptor agonist to reduce risk of colorectal cancer?
di: Iskandar Idris
Pubblicazione: (2024)

Real world data showed that the dual GLP gip agonist, Tirzepatide is associated with lower mortality, cardiovascular events and adverse kidney events compared with GLP‐1 analogue
di: Iskandar Idris
Pubblicazione: (2024)

Tirzepatide shown to be effective at reducing sleep disturbances in patients with obstructive sleep apnoea
di: Iskandar Idris
Pubblicazione: (2024)

Adults who are overweight or obese may experience greater pain intensity compared with normal weight individuals?
di: Iskandar Idris
Pubblicazione: (2024)

The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH)
di: Iskandar Idris
Pubblicazione: (2024)

Increased expression of the protein Kallistatin after weight loss induces beneficial metabolic effects: A potential new therapeutic target?
di: Iskandar Idris
Pubblicazione: (2024)

Increasing excess to weight loss injection shown to save thousands of lives a year
di: Iskandar Idris
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Safety and efficacy of hybrid closed‐loop insulin pump therapy in adolescents and adults with type 1 diabetes in China
di: Jing Shen, et al.
Pubblicazione: (2025)

The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity
di: Iskandar Idris, et al.
Pubblicazione: (2025)

What is the impact of an advanced hybrid closed‐loop system on weight control among people with type 1 diabetes?
di: Sarah Koning, et al.
Pubblicazione: (2025)

Continuous glucose monitoring in early gestational diabetes improves maternal and neonatal outcomes—The Steady Sugar trial
di: Karen Elkind‐Hirsch, et al.
Pubblicazione: (2025)

Pre‐dinner walks may be superior to post‐dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed‐loop insulin delivery systems
di: Lauren V. Turner, et al.
Pubblicazione: (2024)

CGM ‐derived average glucose is more strongly associated with microvascular complications than HbA1c in type 1 diabetes
di: Roland H. Stimson, et al.
Pubblicazione: (2025)

Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice
di: Wanling Lu, et al.
Pubblicazione: (2025)

Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis
di: Satish K. Garg, et al.
Pubblicazione: (2024)

Potential benefits of hybrid closed‐loop systems for managing moderate‐ to high‐risk individuals with type 1 diabetes during Ramadan fasting
di: Abdullah M. Alguwaihes, et al.
Pubblicazione: (2025)

A novel glucose beta‐hydroxybutyrate combination improves hypoglycaemia recovery and patient‐reported outcomes in type 1 diabetes
di: D. Russell‐Jones, et al.
Pubblicazione: (2025)

Real‐time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial
di: Heejun Son, et al.
Pubblicazione: (2025)

Circulating inflammatory proteins are elevated in type 1 and type 2 diabetes and associated to complications
di: Julia I. P. van Heck, et al.
Pubblicazione: (2024)

Effect of introduction of intermittently scanned continuous glucose monitoring on glycaemic control in individuals living with type 2 diabetes mellitus treated with non‐insulin therapies—A randomised controlled trial
di: Emmanuel Ssemmondo, et al.
Pubblicazione: (2024)

Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella review
di: Nathaniel Foo, et al.
Pubblicazione: (2025)